Literature DB >> 28395279

Serum Lymphocyte-Associated Cytokine Concentrations Change More Rapidly over Time in Multiple System Atrophy Compared to Parkinson Disease.

Keri Csencsits-Smith1, Jessika Suescun, Kan Li, Sheng Luo, Diane L Bick, Mya Schiess.   

Abstract

OBJECTIVE: Chronic inflammatory processes contribute to the eventual death of motor neurons and the development of symptoms in both idiopathic Parkinson disease (PD) and multiple system atrophy (MSA). Given the faster rate of progression and more severe symptoms associated with MSA, we hypothesized that markers of inflammation would be more evident in the peripheral blood of MSA than PD patients, and that evidence of this inflammation might assist early diagnosis of MSA versus PD.
METHODS: We performed multiplex analysis to determine the concentrations of 37 immune-associated cytokines and chemokines isolated from the plasma of patients with PD (n = 25) and MSA (n = 14) and compared our results to those of age-matched controls (n = 15). We then applied a mixed-effect multiple regression model to determine if the concentration of cytokines in the plasma of patients with PD and MSA changed significantly over time.
RESULTS: Patients with MSA had a trend towards overall lower levels of immune-associated cytokines, while serum cytokine levels were increased in patients with PD. Statistically adjusted comparisons of overall changes in cytokine concentrations between the PD and MSA groups revealed higher concentrations of T-cell-associated cytokines TNFβ and IL-7 in PD. Comparison of samples taken over time revealed significantly faster rates of change in 4 different cytokine concentrations (IL-4, IL-15, IL-2, and IL-9) in patients with MSA versus patients with PD.
CONCLUSIONS: Our results suggest that single measurements of plasma concentrations of inflammation-associated cytokines cannot be used to distinguish disease states. However, measurements made over time may correlate with pathogenesis. The significant changes in T-cell-associated cytokines may shed light on immune mechanisms that contribute to PD and MSA disease progression.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Chemokines; Cytokines; Neuroinflammation; Parkinsonism

Mesh:

Substances:

Year:  2017        PMID: 28395279      PMCID: PMC5491391          DOI: 10.1159/000460297

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  31 in total

1.  [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy.

Authors:  A Gerhard; R B Banati; G B Goerres; A Cagnin; R Myers; R N Gunn; F Turkheimer; C D Good; C J Mathias; N Quinn; J Schwarz; D J Brooks
Journal:  Neurology       Date:  2003-09-09       Impact factor: 9.910

Review 2.  Th9 cells in the pathogenesis of EAE and multiple sclerosis.

Authors:  Wassim Elyaman; Samia J Khoury
Journal:  Semin Immunopathol       Date:  2016-11-14       Impact factor: 9.623

3.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

4.  Peripheral inflammatory biomarkers and risk of Parkinson's disease.

Authors:  Honglei Chen; Eilis J O'Reilly; Michael A Schwarzschild; Alberto Ascherio
Journal:  Am J Epidemiol       Date:  2007-09-22       Impact factor: 4.897

Review 5.  Disruption of the blood-brain barrier in Parkinson's disease: curse or route to a cure?

Authors:  Heyne Lee; Ilse S Pienaar
Journal:  Front Biosci (Landmark Ed)       Date:  2014-01-01

Review 6.  Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders.

Authors:  Michael J Stuart; Gaurav Singhal; Bernhard T Baune
Journal:  Front Cell Neurosci       Date:  2015-09-10       Impact factor: 5.505

Review 7.  CD8(+) T-Cells as Immune Regulators of Multiple Sclerosis.

Authors:  Sushmita Sinha; Alexander W Boyden; Farah R Itani; Michael P Crawford; Nitin J Karandikar
Journal:  Front Immunol       Date:  2015-12-10       Impact factor: 7.561

8.  The influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort.

Authors:  Konrad Szewczyk-Krolikowski; Paul Tomlinson; Kannan Nithi; Richard Wade-Martins; Kevin Talbot; Yoav Ben-Shlomo; Michele T M Hu
Journal:  Parkinsonism Relat Disord       Date:  2013-10-12       Impact factor: 4.891

9.  Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serum.

Authors:  Daniel Lindqvist; Eli Kaufman; Lena Brundin; Sara Hall; Yulia Surova; Oskar Hansson
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

10.  α-Synuclein and anti-α-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controls.

Authors:  Lynnae M Smith; Mya C Schiess; Mary P Coffey; Andrea C Klaver; David A Loeffler
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

View more
  5 in total

Review 1.  The protective effects of crocin in the management of neurodegenerative diseases: a review.

Authors:  Tahereh Farkhondeh; Saeed Samarghandian; Hanieh Shaterzadeh Yazdi; Fariborz Samini
Journal:  Am J Neurodegener Dis       Date:  2018-02-05

Review 2.  Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson's Disease.

Authors:  Milan Zimmermann; Kathrin Brockmann
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

3.  Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's Disease.

Authors:  Mya Schiess; Jessika Suescun; Marie-Francoise Doursout; Christopher Adams; Charles Green; Jerome G Saltarrelli; Sean Savitz; Timothy M Ellmore
Journal:  Mov Disord       Date:  2021-03-27       Impact factor: 10.338

Review 4.  Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1.

Authors:  Kurt A Jellinger
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

5.  Inflammatory cytokine levels in multiple system atrophy: A protocol for systematic review and meta-analysis.

Authors:  HongZhou Wang; WanHua Wang; ZhongQuan Yi; PanWen Zhao; Hui Zhang; PingLei Pan
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.